Abiomed wins FDA nod for Impella ECP pivotal heart pump trial

Abiomed (Nasdaq:ABMD) announced today that the FDA approved the version of Impella ECP for its upcoming pivotal trial.

Related Keywords

Johnson Medtech ,Mike Minogue ,Abiomed ,Johnson ,Massachusetts Based Abiomed ,Amir Kaki ,John Hospital ,Abiomed Impella ,